Page last updated: 2024-09-04

docetaxel anhydrous and trofosfamide

docetaxel anhydrous has been researched along with trofosfamide in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(trofosfamide)
Trials
(trofosfamide)
Recent Studies (post-2010) (trofosfamide)
12,1103,2166,9201202313

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andritzky, B; Anige, M; Bokemeyer, C; Brandl, S; Burkholder, I; Edler, L; Görn, M; Habermann, CR; Hossfeld, DK; Laack, E; Schuch, G; Thöm, I1

Trials

1 trial(s) available for docetaxel anhydrous and trofosfamide

ArticleYear
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
    Onkologie, 2008, Volume: 31, Issue:4

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Humans; Lung Neoplasms; Middle Aged; Pilot Projects; Practice Patterns, Physicians'; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome

2008
chemdatabank.com